Attached files
| file | filename |
|---|---|
| EX-10.1 - FIRST AMENDMENT TO THE AMENDED AND RESTATED CREDIT AGREEMENT - Option Care Health, Inc. | exhibit10_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________
FORM 8-K
______________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 18, 2011
______________________________________________
BIOSCRIP, INC.
(Exact name of Registrant as specified in its charter)
______________________________________________
|
Delaware
|
0-28740
|
05-0489664
|
||
|
(State of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
|
100 Clearbrook Road, Elmsford, New York
|
10523
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (914) 460-1600
N/A
(Former name or former address, if changed since last report)
______________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01 Entry into a Material Definitive Agreement.
On May 18, 2011, BioScrip, Inc. (referred to herein as “the Company”) entered into the First Amendment and Waiver (the "Amendment") to its Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) dated as of December 28, 2010, by and among the Company, as borrower, all of its subsidiaries as subsidiary guarantors thereto, the lenders party thereto, Healthcare Finance Group, LLC, as administrative agent for the lenders, as collateral agent and as collateral manager for the secured parties, and the other entities party thereto.
Item 9.01 Financial Statements and Exhibits.
The Amendment amends certain of the reporting requirements of the Company set forth in the Amended and Restated Credit Agreement and waives any prior non-compliance relating to such reporting requirements.
The foregoing description of the Amendment is qualified in its entirety by the Amendment filed as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are being filed herewith:
|
Exhibit No.
|
Description
|
|||
|
10.1
|
First Amendment and Waiver to the Amended and Restated Credit Agreement, dated as of May 18, 2011
|
|||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOSCRIP, INC.
|
||||
|
Date: May 23, 2011
|
/s/ Barry A. Posner
|
|||
|
By:
|
Barry A. Posner
|
|||
|
Executive Vice President, Secretary and General Counsel
|
||||
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|||
|
10.1
|
First Amendment to the Amended and Restated Credit Agreement, dated as of May 18, 2011
|
|||